Under construction – not a live service
Sign in
Not yet taking people in PakistanNo phase

Comparing two nerve therapies for pain and balance in diabetic neuropathy

Compares two physical therapies in adults with diabetic nerve damage affecting pain and walking.

Plain-language title generated from the registry record
Registry title: Intraneural Facilitation Therapy and Nerve Flossing Technique in Patients With Diabetic Peripheral Neuropathy

Key facts

Where
Gujranwala, PakistanSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 75 years old?

Source: NCT06663670, who can take part

Where in Pakistan

  • Siddique Family HospitalGujranwala, PakistanNo longer taking part
  • Social Security HospitalGujranwala, PakistanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Riphah International University
Trial code
NCT06663670
Record updated
26 November 2024
Original description
The aim of this study is to determine the comparative effects of intraneural facilitation therapy and nerve flossing technique on pain, balance, gait, and quality of life in Diabetic peripheral neuropathy.Read full original descriptionShow less

Comparative Effects of Intraneural Facilitation Therapy and Nerve Flossing Technique on Pain, Balance, Gait, and Quality of Life in Patients With Diabetic Peripheral Neuropathy

The aim of this study is to determine the comparative effects of intraneural facilitation therapy and nerve flossing technique on pain, balance, gait, and quality of life in Diabetic peripheral neuropathy.

Inclusion: Type 2 diabetes mellitus (diagnosed by the physician); Score >3 on Michigan Neuropathy Screening Instrument-Questionnaire and score >2 on MNSI-Physical Examination; Diabetic peripheral neuropathy symptoms below the ankle (numbness, tingling, burning, sharp pain, increased sensitivity, etc.).

Exclusion: Active inflammations or other inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy, proximal diabetic neuropathy, chemotherapy-induced peripheral neuropathy, autonomic neuropathies, or other neuropathies not associated with DM such as B12 deficiency; Presence of any other systemic disease rather than diabetes such as end-stage renal failure, uncontrolled hypertension, severe dyslipidemia, chronic liver disease, autoimmune disease, advanced chronic obstructive pulmonary disease, etc; Diabetic ulcer in either foot; History of fracture, strain, history of trauma leading to nerve injuries in the last year; Total or partial amputation of lower extremities.

ClinicalTrials.gov NCT06663670